Skip to main content

Palo Alto Investors LP

Position in NBIX — Neurocrine Biosciences Inc

CIK 1306923 PALO ALTO, CA

Position in NBIX

as of Jun 30, 2026 · filed Aug 19, 2026
Position Value
$3,053,439
+$666,706 QoQ
Shares Held
18,117
0.0% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
#263
of 772 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Palo Alto Investors LP holds $50,502,024 across 4 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (6.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 NBIX
Neurocrine Biosciences Inc
This page
18,117 $3,053,439

All Filings in NBIX

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,053,439 18,117
2026-03-31 $2,386,733 18,117
2025-12-31 $2,569,534 18,117
2025-09-30 $2,543,264 18,117
2025-06-30 $1,675,950 13,334
2025-03-31 $1,474,740 13,334